医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(R)-1-Boc-2-氰基吡咯烷 | tert-butyl 2-cyanopyrrolidine-1-carboxylate | 144688-70-0 | C10H16N2O2 |
|
(R)-1-BOC-3-氟吡咯烷 | (R)-1-N-tert-butoxycarbonyl-3-fluoropyrrolidine | 876617-25-3 | C9H16FNO2 |
|
(R)-1-BOC-2-羟甲基哌嗪 | tert-butyl (R)-2-(hydroxymethyl)piperazine-1-carboxylate | 169448-87-7 | C10H20N2O3 |
|
(R)-1-(甲氧基(甲基)氨基)-1-氧代-2-丙基氨基甲酸叔丁酯 | tert-butyl N-[(1R)-2-[methoxy(methyl)amino]-1-methyl-2-oxo-ethyl]carbamate | 146553-06-2 | C10H20N2O4 |
|
(R)-1-(3-氯苯基)乙醇 | (R)-1-(3-chlorophenyl)-ethanol | 120121-01-9 | C8H9ClO |
|
(R)-1-(3-氯苯基)乙胺 | (R)-1-(3-chlorophenyl)ethanamine | 17061-53-9 | C8H10ClN |
|
(R)-1-(2-氟苯基)乙胺 | (R)-1-(2-fluorophenyl)ethan-1-amine | 185545-90-8 | C8H10FN |
|
(R)-1-(2,6-二氯-3-氟苯基)乙醇 | (R)-1-(2,6-dichloro-3-fluorophenyl)ethanol | 330156-50-8 | C8H7Cl2FO |
|
(R)-1-(1-丙烯酰基哌啶-3-基)-4-氨基-3-(4-苯氧基苯基)-1H-咪唑并[4,5-C]吡啶-2(3H)-酮 | tolebrutinib | 1971920-73-6 | C26H25N5O3 |
|
(R)-1,3-二甲基哌嗪-2-酮盐酸盐 | (R)-1,3-dimethylpiperazine-2-one hydrochloride | 1373232-29-1 | C6H12N2O*ClH |
|
(R)-1,2-二噻茂烷-3-戊酸钠 | sodium lipoic acid | 176110-81-9 | C8H13O2S2*Na |
|
(R)-(-)-8a-甲基-3,4,8,8a-四氢-1,6(2H,7H)-萘二酮 | (R)-Wieland-Miescher ketone | 100348-93-4 | C11H14O2 |
|
(R)-(-)-4-氨基-3-羟基丁酸 | (R)-4-Amino-3-hydroxybutanoic acid | 7013-07-2 | C4H9NO3 |
|
(R)-(-)-4-(3-吲哚氧基甲基)-2-恶唑烷酮 | 4-(1H,indol-3-ylmethyl)-2-oxazolidinone | 157636-81-2 | C12H12N2O2 |
|
(R)-(-)-3-氨基哌啶 二盐酸盐 | (R)-3-Aminopiperidine dihydrochloride | 334618-23-4 | C5H14Cl2N2 |
|
(R)-(-)-3-异丙基-2,5-哌嗪二酮 | (R)-3-isopropylpiperazine-2,5-dione | 143673-66-9 | C7H12N2O2 |
|
(R)-(-)-3-奎宁醇 | (R)-quinuclidin-3-ol | 25333-42-0 | C7H13NO |
|
(R)-(-)-3-(氨甲酰甲基)-5-甲基己酸 | (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid | 181289-33-8 | C9H17NO3 |
|
(R)-(-)-2-甲基戊二酸 | (R)-2-methylglutaric acid | 1115-81-7 | C6H10O4 |
|
(R)-(-)-2-甲基哌嗪 | (2R)-methylpiperazine | 75336-86-6 | C5H12N2 |
|
(R)-(-)-1-甲基-3-羟基吡咯烷 | (R)-1-methyl-3-pyrrolidinol | 104641-60-3 | C5H11NO |
|
(R)-(-)-1-氨基茚盐酸盐 | (R)-2,3-dihydro-1H-inden-1-amine hydrochloride | 10305-73-4 | C9H11N*ClH |
|
(R)-(+)-叔丁基亚磺酰胺 | (R)-2-methylpropane-2-sulfinamide | 196929-78-9 | C4H11NOS |
|
(R)-(+)-alpha-氨基-gamma-丁内酯盐酸盐 | (R)-α-amino-γ-butyrolactone hydrochloride | 104347-13-9 | C4H7NO2*ClH |
|
(R)-(+)-5’-甲氧基劳丹素 | 5'-methoxylaudanosine | 24734-71-2 | C22H29NO5 |
|
(R)-(+)-3-羟基-3-苯丙酸 | (R)-3-phenyl-3-hydroxypropionic acid | 2768-42-5 | C9H10O3 |
|
(R)-(+)-3-甲基琥珀酸单甲酯 | (R)-2-methyl-succinic acid 4-methyl ester | 81025-83-4 | C6H10O4 |
|
(R)-(+)-2-苄氧基丙酸 | (R)-2-benzyloxypropionic acid | 100836-85-9 | C10H12O3 |
|
(R)-(+)-2-(二苯甲基)吡咯烷 | (R)-2-(diphenylmethyl)pyrrolidine | 22348-31-8 | C17H19N |
|
(R)-(+)-2-(Α-甲基苄氨基)-5-硝基吡啶 | 2-(R-1-phenylethylamino)-5-nitropyridine | 64138-65-4 | C13H13N3O2 |
|
(R)-(+)-1-Boc-2-吡咯烷甲腈 | tert-butyl (R)-2-cyanopyrrolidine-1-carboxylate | 228244-20-0 | C10H16N2O2 |
|
(R)-(+)-1-(4-吡啶基)乙醇 | (R)-1-(4-Pyridyl)ethanol | 27854-88-2 | C7H9NO |
|
(OC-6-22)-三[5-甲基-2-(2-吡啶基)苯基]铱 | Ir(mppy)3 | 149005-33-4 | C36H33IrN3+3 |
|
(E)7-[2-环丙基-4-(4-氟苯基)-喹啉-3-基]-(3S,5S)-二羟基庚-6-烯酸乙酯 | (E)7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl]-(3S,5S)-dihydroxyhept-6-enic acid ethyl ester | 380848-30-6 | C27H28FNO4 |
|
(E)-辛-4-烯-1,8-二酸 | (E)-oct-4-ene-1,8-dioic acid | 48059-97-8 | C8H12O4 |
|
(E)-乙苯亚甲基丁二酸 | trans-phenylitaconic acid | 5653-88-3 | C11H10O4 |
|
(E)-ψ-紫罗兰酮 | pseudoionone | 3548-78-5 | C13H20O |
|
(E)-beta-(4-氯苯基)丙烯酰苯 | 4-chlorochalcone | 22252-16-0 | C15H11ClO |
|
(E)-N-(2-氯-6-甲基苯基)-3-乙氧基丙烯酰胺 | (E)-N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide | 863127-76-8 | C12H14ClNO2 |
|
(E)-5-(2-溴乙烯基)尿嘧啶 | (E)-5-(2-bromovinyl)uracil | 69304-49-0 | C6H5BrN2O2 |
|
(E)-4-碘-N-(噻吩-2-基亚甲基)苯胺 | 4-iodo-<i>N</i>-thiophen-2-ylmethylene-aniline | 15310-76-6 | C11H8INS |
|
(E)-4-(4-(二十六烷基氨基)苯乙烯基)-1-甲基吡啶鎓碘化物 | Diasp | 114041-00-8 | C46H79IN2 |
|
(E)-3-[2-(7-氯-2-喹啉基)乙烯基]苯甲醛 | (E)-3-[2-(7-chloro-2-quinolinyl)ethenyl]benzaldehyde | 120578-03-2 | C18H12ClNO |
|
(E)-3-(二甲基氨基)-1-(吡啶-4-基)丙-2-烯-1-酮 | (E)-3-(dimethylamino)-1-(pyridin-4-yl)prop-2-en-1-one | 123367-27-1 | C10H12N2O |
|
(E)-3-(二甲基氨基)-1-(吡啶-3-基)丙-2-烯-1-酮 | (E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one | 123367-26-0 | C10H12N2O |
|
(E)-3-(5-硝基-1-环己烯-1-基)丙烯酸 | 3-(5-nitro-cyclohex-1-enyl)-acrylic acid | 899809-64-4 | C9H11NO4 |
|
(E)-3-(3,4-二甲氧基苯基)-1-(3-羟基苯基)-1-丙酮 | (E)-3-(3,4-dimethoxyphenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one | 178445-80-2 | C17H16O4 |
|
(E)-3,4,5-三甲氧基苯甲醛肟 | (E)-3,4,5-trimethoxybenzaldehyde oxime | 39201-89-3 | C10H13NO4 |
|
(E)-2-甲基-2-丁烯酸异丙酯 | disodium;3-[[4-[(3-carboxy-4-oxidophenyl)diazenyl]benzoyl]amino]propanoate | 213594-60-6 | C17H13N3Na2O6 |
|
(E)-2-[2-[2-[[5-[4-[BOC-(甲基)氨基]苯乙烯基]-2-吡啶基]氧基]乙氧基]乙氧基]乙基-4-甲基苯磺酸酯 | AV-105 | 1205550-99-7 | C32H40N2O8S |
|